Compared to mice receiving control-shRNA-transduced GSCs (control GSCs), mice grafted with METTL3 KD GSCs exhibited much bigger tumors, as revealed by a substantial increase in tumor bioluminescence intensity (Figures 5B–5D). Here, METTL3 is linked to neoplasm.